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ABSTRACT
High grade serous ovarian carcinoma (HGSC) is a DNA instable tumor and its 
precursor is commonly found originating from the fimbriated end of the fallopian 
tube secretory epithelial (FTSE) cells. The local stresses via ovulation and related 
inflammation are risks for HGSC. In this study, we examined the cellular and molecular 
responses of FTSE cells to stress. We found that excess intracellular reactive oxygen 
species (ROS) in normal FTSE cells upregulated a subset of microRNA expression 
(defined as ROSmiRs). Most ROSmiRs’ expression and function were influenced and 
regulated by p53, and together they drove the cells into stress-induced premature 
senescence (SIPS). However, ROS-induced miR-182 is regulated by β-catenin, not 
by p53. In normal FTSE cells, miR-182 overexpression triggers cellular senescence 
by p53-mediated upregulation of p21. Conversely, in cells with p53 mutations, miR-
182 overexpression no longer enhances p21 but functions as an “Onco-miR”. p53 
dysfunction is a prerequisite for miR-182-mediated tumorigenesis. In addition, we 
found that human follicular fluid could significantly induce intracellular ROS in normal 
FTSE cells. These findings suggest that ROS and p53 mutations may trigger a series 
of events, beginning with overexpressing miR-182 by ROS and β-catenin, impairing 
the DNA damage response, promoting DNA instability, bypassing senescence and 
eventually leading to DNA instable tumors in FTSE cells.
INTRODUCTION
Despite the significant efforts of basic and clinical 
research, the survival rate of women with ovarian 
carcinoma has not changed significantly in the past 
fifty years [1] . High grade serous ovarian carcinoma 
(HGSC) is the most common type and is a deadly form of 
ovarian cancer and early diagnosis remains a challenge. 
HGSC encompasses DNA-instable tumors with frequent 
BRCA1/2 [2] and p53 mutations [3], wherein p53 mutation 
alone is not sufficient to trigger a sequence of neoplasia 
[4]. A recent mouse model by combining inactivation of 
brca/p53/pten produced tumors mimicking human HGSC 
[5] indicates these tumor suppressor genes are critical in 
the development of HGSC.
Recent studies suggest that some miRNAs are 
sensitive to oxidative stress (OS), and that ROS exposure 
can induce the expression of specific microRNAs [6, 7]. 
These miRNAs react to stresses through coordination 
of the target gene regulation. Interestingly, most stress-
induced miRNAs are mediated by p53 [8]. It can be 
speculated that the stress-induced miRNA expression 
and p53 function may play a central role in determining 
the cell fate and may trigger sequential and as of yet, not 
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fully characterized pathways, thus increasing the risk for 
HGSC transformation. Fallopian tube secretory epithelial 
(FTSE), but not ciliate (FTCE) cells are the cell origin 
of HGSC [9]. HGSC precursor lesions, known as serous 
tubal intraepithelial carcinoma (STIC) [10, 11], exist in 
the distal (fimbriated) ends of the fallopian tubes but are 
rarely seen elsewhere. While the mechanisms for why 
FTSE at fimbriae are the targets of HGSC remain largely 
unknown, as local microenvironmental stress induced by 
ovulation is a risk factor for ovarian cancer [12]. Monthly 
ovulation may produce trauma-induced inflammation and 
unbalanced ROS for local OS [13]. Cellular response to 
microenvironmental stresses is intricately regulated by 
a complex network of molecules. While stress-induced 
premature cellular senescence (SIPS) has been considered 
as a protective mechanism against tumorigenesis as the 
accumulation of cells undergoing SIPS may contribute 
to double strand DNA breaks, mitochondrial OS injury, 
chronic inflammation, abnormal proliferation and cellular 
transformation [14]. How normal and defected FTSE cells 
respond to OS should be investigated.
To investigate how FTSE cells react to stress, in this 
study, we examined ROS-induced miRNA (we defined as 
ROSmiRs) dysregulation and their molecular regulation 
mechanism; miRNA functions in response to OS in the 
presence and absence of p53; and the major stress mediator 
ROS, which is highly induced by follicular fluid and the 
inflammatory cytokines. We found that FTSE cells were 
vulnerable to local stress and the ROSmiRs play a critical 
role in normal and abnormal FTSE cells. Disrupting the 
balance between stress and miRNA expression, especially 
miR-182, results in the impaired DNA damage response, 
senescence bypass, risk for tumor transformation and 
eventual development of DNA instable HGSC.
RESULTS
ROS- induced miRNA (ROSmiR) and mRNA 
expression in FTE cells
Many studies used H
2
O
2
 to mimic the function of 
ROS/superoxide in different type of cells. To explore 
ROSmiRs expression in FTE cells, a global miRNA 
profiling analysis in cultured primary FTE cells was 
examined. We found a subset of miRNAs that were 
significantly dysregulated in FTE cells after H
2
O
2
 exposure 
including let-7s, miR-34s, and miR-200s and miR-182 
family members (Figure 1A, Suppl Table 1, Suppl Figure 
1A). Moreover, upregulation of three different forms 
of miR-182 (pre-, pri- and mature) and miR-182 family 
members (miR-96 and miR-183) suggests ROS-induced 
miR-182 is at transcriptional level and dose dependent 
in primary FTE (Figure 1B) and immortalized FTSE cell 
lines (Suppl Figure 1B).
Many ROSmiRs (let-7s, miR-34s and miR-200s) 
seemed to be p53 dependent [8]. To investigate whether 
ROS induced miRNA expression was p53 dependent, we 
first examined ROSmiR expression in FTSE cell lines. 
FTE237 was immortalized by sh-p53 (Suppl Table 2) and 
absent of p53 expression, while FTE194 had moderate 
TP53 expression. When both cells were treated by 100 μM 
H
2
O
2
 for 24 hours, miR-182 upregulation was noted (data 
not shown). To determine the role of p53 in ROSmiR 
expression, the primary cultured FTE cells were prepared 
in ex vivo culture, in which, p53 was blocked by sh-p53. 
Similar to FTSE cell lines, cells were treated with 50 μM 
H
2
O
2
 and ROSmiR expression were examined by real-time 
RT-PCR (Figure 1C). Both miR-182 and miR-200c were 
inducible when p53 was present, but only miR-182 was 
significantly induced by H
2
O
2
 when p53 was blocked by 
sh-p53. We found among most ROSmiRs, miR-182 was 
highly induced by ROS in cells with and without p53 
expression.
ROS resulted in significant gene alterations in 
primary culture FTE cells. Gene profiling analysis 
revealed a total of 88 genes were upregulated and 
134 genes were downregulated by ROS (p < 0.05, 
Figure 1D, Suppl Table 3A and 3B). Further analysis 
showed that ROS induced gene dysregulation involved 
mainly in cell cycle, DNA replication, p53 signaling 
pathway (Figure 1E).
Taken together, ROS induces a subset of miRNAs 
in FTE cells and most of them are mediated by p53 
expression, but miR-182 is an exception.
ROS- induced premature cellular senescence 
through ROSmiRs
ROS can be double-edged swords in reproductive 
organs depending on their level and intensity in cells [13]. 
The effects of oxidative stress on female reproduction and 
related diseases involve many different pathophysiologic 
mechanisms [13]. The major effects of ROS on cellular 
toxicity include DNA stress, SIPS/cell cycle arrest, and 
cell death. To evaluate the cellular response of ROS in 
FTE cells, we simply exposed H
2
O
2
 in different dosages 
in primary FTE and immortalized FTSE cells. 50 μM and 
higher H
2
O
2
 triggered SIPS of FTE cells (Figure 2A). 
This is consistent with previous reports on many ROSmiR 
(miR-34s, miR-200s and let-7s) in different cell types [15]. 
In this study, we overexpressed miR-182 in FTSE cell lines 
and found miR-182 overexpression can trigger significant 
cellular senescence in primary FTE and immortalized 
FTSE cells (Figure 2B, Suppl Figure 2A and 2B).
Among the top dysregulated ROSmiRs in FTE cells 
(Figure 1A), miR-34s, miR-200s and let-7s have been 
reported to regulate cell cycles and promote SIPS. We 
recently reported that overexpression of miR-182 [16] and 
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miR-200a [17] can trigger significant cellular senescence 
in uterine leiomyoma. These findings prompted us to test 
whether ROS-induced SIPS is through ROSmiRs. We 
overexpressed miR-182 in FTSE cell lines and examined 
cellular senescence and several cell cycle negative 
regulators in primary and immortalized FTE cells. p21 
was one of the major genes influenced by miR-182. 
When introducing miR-182 overexpression in FTE194, 
we noted not only the triggering of significant cellular 
senescence (Suppl Figure 2A) but also upregulated P21 
expression with or without ROS exposure (Figure 2C, 
Suppl Figure 2C). Moreover, miR-182 mediated 
P21 upregulation was dose dependent (Figure 2D). 
Furthermore, the level of P21 expression by miR-182 was 
much higher than simply ROS exposure and anti-miR-182 
treatment was able to block P21 expression (Figure 2C, 
Suppl Figure 2C). Interestingly, miR-182 mediated P21 
upregulation was not observed in cell line FTE237, which 
was immortalized by sh-p53, and no detectable p53 
expression was noted (Suppl Figure 2D) [18]. To assess 
whether miR-182 mediated P21 upregulation requires 
P53, p53 expression was inhibited by lentiviral sh-p53 in 
leiomyoma cell line DD-HLM (Figure 2E) and FTE194 
(Figure 2F) and then overexpressed miR-182. We noted 
that only blocking p53 expression resulted in abolishing 
miR-182 mediated P21 upregulation in leiomyoma cells 
(Figure 2E) and FTSE cells (Figure 2F). Findings strongly 
suggest that miR-182 triggers SIPS by upregulation of p21 
and this process requires functional p53.
ROS or stress-induced miR-182 is through 
β-catenin when P53 is inactivated
As illustrated above, ROS significantly induces miR-
182 overexpression (Figure 1). MiR-182 overexpression 
further triggers SIPS through upregulation of p21 in the 
Figure 1: ROS-induced miRNA (ROSmiRs) and mRNA expression in FTE cells. A. Dendrogram illustrated ROS-induced 
miRNAs (ROSmiRs, >1.5 fold dysregulation) in primary FTE cells (n = 3) treated with DMSO (Ctrl) and ROS (H
2
O
2
 50 μM). B. ROSmiR 
expression including pri-, pre- and mature miR-182 and its family member miR-96 when primary FTE cells were treated with different 
concentrations of H
2
O
2
 (0: open box, 25 μM: gray box; 50 μM: dark box). C. The selected ROSmiR expression in primary FTE cells by 
blocking p53 (lower panel) expression (sh-p53) and vector control (upper panel) followed by H
2
O
2
 (100 μM) for 24 hours. D. Dendrogram 
illustrated top dysregulated genes (>1.5 fold) in primary FTE cells (n = 3) treated with DMSO (control) and ROS (H
2
O
2
 50 μM). E. Pathway 
analysis of ROS-induced gene expression of primary FTE cells in cell function pathways. *p < 0.05, **p < 0.01, ***p < 0.001.
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presence of p53 (Figure 2). Other ROSmiRs, including 
miR-34s, miR-200s and let-7s, also contribute to ROS-
induced senescence and p21 upregulation [19–21]. Given 
that most of the ROSmiRs are directly or indirectly 
regulated by p53 [8] (Figure 1E), and p53 is frequently 
mutated during the early and later stages of high-grade 
serous carcinoma, the role of p53 independent ROSmiR, 
such as miR-182 expression and its function in FTE cells, 
seems to be pivotal when p53 is partly or completely 
inactivated. To explore what molecular mechanisms are 
involved with ROS-induced miR-182 expression in FTE 
cells, we examined several candidate genes that respond 
to ROS and potentially regulate miR-182 expression. 
Initial screening showed that β-catenin was significantly 
upregulated by ROS (Suppl Figure 3A) and/or h-FF 
(Suppl Figure 1C). Further study showed that β-catenin is 
constantly upregulated when administering ROS in ex vivo 
culture of primary FTE cells (Figure 3A). ROS upregulates 
β-catenin expression can also be repeated in FTSE cell line 
(Figure 3B, Suppl Figure 3B). ROS upregulating β-catenin 
could be detected at 30 min after ROS exposure and reach 
to peak at 2 hours (Figure 3B), and seemed to be dose 
dependent (Suppl Figure 3B). Immunofluorescent staining 
revealed that ROS-induced β-catenin had significant 
cytoplasmic to nucleus translocation (Figure 3C) and 
this could be further confirmed by western blot analysis 
(Figure 3D).
To evaluate how β-catenin regulates miR-182 
expression in FTE cells, β-catenin was overexpressed by 
introducing the adenovirus β-catenin construct Ad-S37A-
β-cat-HA in FTSE cell lines, and miR-182 expression 
was examined. We found β-catenin upregulated miR-
182 expression, and it was dose dependent (Figure 3E, 
Suppl Figure 3). When repeating the same experiment 
Figure 2: ROS-induced premature cellular senescence is mediated by ROSmiRs and cell cycle genes. A. ROS (H
2
O
2
 
50 μM)-induced premature cellular senescence in primary FTE cells was detected by SA-β-gal staining (left) and counted senescent rate 
(percentage) in control (Ctrl, open box) and H
2
O
2
. B. The percentage of senescent cells was counted in FTE194 cells with (dark box) and 
without (open box) miR-182 overexpression. Three randomly selected fields (1 × 1 mm2) of images were captured to count the senescence 
rate (%). **p < 0.01, ***p < 0.001. C. P21 expression were examined by western blot in FTE194 cells by controlling miR-182 expression 
and treated with H
2
O
2
 (100 μM). D. P21 expression in FTE194 cells by administrations of different doses of miR-182 mimic (0–60 nM). 
E and F. P21 and P53 expression in uterine smooth muscle cell line, DD-HLM (E) and FTE194 (F) cells by controlling miR-182 expression, 
blocking p53 expression by sh-p53 and treating with H
2
O
2
. Protein band intensity was measured by density photometry and is listed below. 
β-actin was used as a protein loading control.
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Figure 3: ROS or stress-induced miR-182 expression is regulated by β-catenin. A. β-catenin mRNA expression in primary 
FTE cells (n = 3) treated by DMSO (ctrl) and H
2
O
2
 detected by real time RT-PCR. B. Time (0–2 hours) and dose (0–200 μM) effect of 
H
2
O
2
 on β-catenin protein expression detected by western blot in the FTE194 cell line. C. Immunofluorescent image analysis of β-catenin 
expression (counterstained with DAPI, blue color) and cellular location in FTE194 cells with and without H
2
O
2
 exposure. D. Western blot 
analysis of β-catenin expression in FTE194 cells extracted from nuclear (N) and cytoplasmic (C) fraction with and without H
2
O
2
 exposure. 
β-actin was used as a protein loading control. E and F. To determine whether β-catenin specifically regulated miR-182 expression, β-catenin 
expression was controlled by different doses of β-catenin in the quantitative adenovirus infection by β-catenin construct Ad-S37A-β-cat-
HA (×106 PFU/ml) in FTE194 cells. β-catenin (hollow dot), miR-182 (dark square), and miR-200a (triangle dot) expression was detected 
by real time RT-PCR (E). MiR-182 expression was further examined when β-catenin expression was inhibited by si-RNA (F). *p < 0.05, 
**p < 0.01, ***p < 0.001.
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to examine other ROSmiR (miR-200a) expression by 
β-catenin, no significant change was found (Figure 3E). 
When blocking β-catenin expression by si-RNA, ROS-
induced miR-182 expression was significantly reduced 
(Figure 3F). Findings suggest that ROS-induced miR-
182 expression is mostly through ROS-induced β-catenin 
expression and its nuclear translocation.
Upregulation of miR-182 enhances senescence 
bypass in FTSE cells when exposed to ROS or 
DNA stress
Expression of senescence-associated ROSmiR 
in FTSE cells requires p53 when exposed to ROS [8] 
(Figure 1). When p53 is intact, these ROSmiRs including 
miR-182 function as tumor suppressors or cell cycle 
inhibitors by triggering SIPS (Figure 2). However, 
when p53 is lost, ROS upregulates miR-182 through the 
β-catenin pathway, but miR-182 mediated p21 upregulation 
is aborted (Figure 2E, 2F). How do the FTSE cells react 
to stress when p53 is lost or mutated? To address this 
question, we established stable overexpression of miR-182 
in the immortalized FTSE cell lines. The same cell lines 
without miR-182 overexpression were used as controls. 
All control and test cells were treated with Doxorubicin 
(DOX), a potent DNA damage reagent, and we found 
significant SIPS in all cell types (Suppl Figure 4A). 
However, in addition to higher senescent rate in cells 
with miR-182 overexpression (Suppl Figure 4A), these 
cells also obtained a significantly high-rate of senescence 
bypass when treated with ROS or DOX (Figure 4A).
To further evaluate the cellular nature of the 
senescence bypassed FTSE cells with and without 
miR-182 overexpression, FTE194 cells were stably 
overexpressed with luciferase and grafted into the 
intrabursa in nude mice (for detailed techniques, please 
refer to our recent publication [22]). We used IVIS to 
monitor the cell growth each week (Figure 4B). At the end 
of 180 days, cell growth was detectable in 45% (9/20) of 
FTSE cells with miR-182 overexpression and only in 10% 
(1/10) of implants in the control group (Figure 4C). The 
data from FTE237 cells were similar (data not shown). 
Although no tumor formation was noted in all of the 
mice, long-lasting cell growth of FTSE with miR-182 
overexpression suggesting the role of promoting cell 
proliferation and independent growth by miR-182 when 
p53 is partly inactivated (Figure 4C).
One of the major functions for miR-182 involves 
the DNA damage response [23]. To investigate the role 
of miR-182 in DNA integrity and the chances of tumor 
transformation, we isolated the senescence bypass FTSE 
cells with and without miR-182 overexpression and treated 
with lower doses (25–50 μM) of H
2
O
2
 in each passage and 
propagated up to 15 passages (to mimic chronic stress 
in vitro). These chronically stressed cells with miR-182 
overexpression can occasionally transformed in vitro, 
detected by soft agar (Figure 4D). DNA alterations were 
characterized by a significant increase of aneuploidy in 
FTSE cells with miR-182 overexpression (Figure 4E, 
Suppl Figure 4B).
Different reactions to ROS and DNA damage 
response between FTSE and FTCE cells
Normal fallopian tube consists of two major cell 
types, secretory (FTSE) and ciliated (FTCE) surface 
epithelial cells. Compelling evidence supports that most 
high-grade serous carcinoma arise from FTSE cells 
[10, 11]. Recent study showed that FTSE cells seemed 
to have a delayed DNA damage response (DDR) in 
comparison to FTCE cells [18]. To further investigate 
whether these two cell types react differently to ROS, 
we examined the stress response in FTSE and FTCE 
cells. When ex vivo primary culture of FTE cells was 
established (Suppl Figure 5A), pure epithelial cells 
gated by anti-CD326 (EpCAM). FTE cells were then 
sorted with anti-LhS28-APC, a ciliate surface protein, 
by flow cytometry (Figure 5A). Overall, 15–30% of cells 
were FTCE cells. To further evaluate the sorting results, 
the sorted cells were subjected to RT-PCR analysis in 
the selected FTSE and FTCE cell markers. The gene 
expression patterns in the sorted cells indicated that 
the sorting was successful (Figure 5B). The cells were 
also evaluated by immunofluorescent stain of PAX8 
(secretory marker) and LhS28 (ciliated marker) (Suppl 
Figure 5B). We found that the baseline β-catenin and 
miR-182 family members were higher in FTSE than in 
FTCE cells (Figure 5C).
Next, the sorted FTSE and FTCE cells were exposed 
to different doses of ROS for 24 hrs. While exposed to 
50 μM ROS, both cell types had elevated β-catenin, but 
FTSE cells had three to seven fold higher β-catenin than 
FTCE cells (Figure 5D). Consistent with β-catenin reaction, 
miR-182 and its family members were also significantly 
higher in FTSE cells than in FTCE cells when exposed to 
ROS (Figure 5D). Findings suggest that FTSE and FTCE 
cells react differently to ROS and ROS induced genes.
MiR-182 overexpression significantly inhibits 
DNA damage response through its negative regulation of 
DNA repair genes, BRCA1 and FOXO3a [23, 24]. In this 
study, we first examined DNA damage repair dynamics in 
FTE194 cell lines. The cells with and without miR-182 
overexpression treated with ROS and anti-miR-182, DNA 
damage repair were examined by immunofluorescent 
stain, H2AX at time points of 0, 8 and 48 hours. The 
levels of H2AX immunoreactivity were examined by 
fluorescent microscope (Figure 5E) and ELISA-based 
intensity measurement (Figure 5F). Apparently, miR-
182 overexpression significantly slowed DNA repair 
after 48 hours of ROS exposure. Next, we examined 
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DNA damage response (DDR) between FTSE and FTCE 
cells. The positive cells with H2AX stain were counted. 
We found FTSE cells had less than 10% of DNA repair, 
in contrast, FTCE had nearly 50% of DNA repair after 
48 hours of ROS exposure. In the same experiment 
setting, transient transfection of anti-miR-182 along 
with ROS exposure would significantly improve DDR to 
55% of FTSE cells and 70% of FTCE cells at 48 hours, 
respectively (Figure 5G). Findings suggest that higher 
levels of β-catenin and miR-182 expression in FTSE cells 
Figure 4: miR-182 enhances senescence bypass in FTSE cells under DNA stress and impaired p53. A. Senescence bypass 
was evaluated by colony formation assay in FTE194 and FTE237 cell lines with and without miR-182 overexpression after doxorubicin 
(DOX, 0.2 μg/ml) or H
2
O
2
 (100 μM) treatment. B and C. Senescence bypassed FTE194 cells with (test) and without (control) miR-182 
overexpression were stably transfected with luciferase and grafted into the intrabursa in nude mice (B). Cell growth was monitored by IVIS 
weakly, up to 180 days. The number of detectable xenografts (B) and cell growth rate (C) were measured and counted. D. Soft agar assays 
showed that chronic stress treatment in FTE194 and FTE237 cells with (test) and without (control) miR-182 overexpression increased 
anchorage independent growth. E. FTE194 cells with and without miR-182 overexpression were chronically treated with low dose of H
2
O
2
 
exposure (10 μM) in each passage and up to 15 passages. Karyotypes were prepared and analyzed in FTE194 (n = 50) and FTE194 with 
miR-182 overexpression (n = 100) and the aneuploidy was counted and summarized in dotplots (bottom). ***p < 0.001.
Oncotarget38990www.impactjournals.com/oncotarget
Figure 5: Differential reaction to ROS and DNA damage response between FTSE and FTCE cells. A. FTSE and FTCE 
cells were sorted by flow cytometry BD FACSAria 5-Laser in ex vivo cultured primary FTE cells labeled by APC conjugated anti-LhS28. 
B. The unsorted FTE cells (gray box) and sorted FTSE (dark box) and FTCE (open box) cells were subjected to cell type specific biomarker 
analysis by real-time RT-PCR for secretory cells (top panel) and ciliated cells (bottom panel). C and D. β-Catenin and miR-182 expression 
was detected in the sorted FTSE and FTCE cells with and without ROS treatment. E and F. DNA damage response in ex vivo culture of 
total FTE cells with or without miR-182 transient transfection. Cells were treated with H
2
O
2
 (50 μM) and DNA damage was examined by 
immunofluorescent staining of γ-H2A.X at time points of 0, 8 and 48 hours. Total protein was extracted from cell pellets and added to 96 
well plate coated with γ-H2AX antibody. Goat anti-Mouse IgM HRP Conjugate was used and results were taken by chemiluminescent 
readings using a Cytation 3 Cell Imaging Multi-Mode Reader in three time points for control (open dot), anti-miR-182 (dark square) and 
miR-182 mimic (triangle). Determination of γ-H2AX concentrations was done and shown as pM/106 cells. G. DNA damage response in ex 
vivo culture of the sorted FTSE (dark box) and FTCE (open box) cells with or without miR-182 overexpression (by transient transfection 60 
nM miR-182 mimic) and anti-miR-182 treatment. DNA damage was examined by immunofluorescent staining of γ-H2A.X at time points 
of 0, 8 and 48 hours. The positive cells with γ-H2A.X staining (> 10 dots/nucleus) were counted. *p < 0.05, **p < 0.01, ***p < 0.001.
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slow down DNA damage repair and this may result in 
increasing the risk of DNA alteration.
Follicular fluid - induction of ROS in FTSE cells
Monthly ovulation in women produces local stress 
and trauma on the ovarian surface. FTSE cells at the 
fimbriated end are directly exposed to human ovulatory 
follicular fluid (h-FF) and the local inflammatory 
environment [25]. It is well recognized that ovulation is a 
major stressor for the surrounding cells, causing trauma-
induced inflammation and local oxidative stress [12]. 
To investigate how the FTE cells react to h-FF and 
inflammatory cytokines, we examine ROS production 
in primary and immortalized FTE cells. The primary 
FTE cells were exposed to 50 μl/ml h-FF for up to 
24 hours, and a significant increase in ROS production 
was noted (Figure 6A). The finding was repeatable in at 
least three independent experiments from the different 
cases. To quantify ROS production, ROS intensity was 
measured and plotted by flow cytometry (Figure 6A). 
Likewise, similar findings were observed in immortalized 
FTSE cell lines (Suppl Figure 6A). To evaluate h-FF 
induced ROS in FTE cells, we treated h-FF with 56 and 
Figure 6: Follicular fluid for ROS induction in fallopian tube epithelial cells. A. Human follicular fluid (h-FF, 50 μl/ml) 
induced ROS production in ex vivo culture of primary FTE cells at 4 and 24 hours. ROS intensity was detected by DHE (10 μM) stain and 
observed under a fluorescence microscope at excitation and emission wavelengths of 518/605 nm. H
2
O
2
 (50 μM) treatment was used as a 
positive control. To quantify ROS production, the fluorescent intensity was measured by flow cytometry. The plotting histogram showed 
the cell counts of the test (red solid line) and control (black dashed line) in cells treated with h-FF (left) and positive control of H
2
O
2
 (right). 
B. NAC (5 mM) was added 1 hour prior to h-FF or H
2
O
2
 treatment. The intensity of ROS was illustrated under the fluorescence microscope 
(upper) and plotting histogram (bottom). C. The histograms summarized the quantitative measurement of mean fluorescent intensity of 
ROS productions induced by h-FF and b-FF. Non-treated cells (open box) and H
2
O
2
 (50 μM) treated cells (dark-black box) were used as 
negative and positive controls. The data was generated in different cases. *p < 0.05, ***p < 0.001.
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96°C and similar results were obtained (data not shown). 
To determine whether cellular fluorescent signals induced 
by h-FF were from ROS, cells were treated with ROS 
inhibitor, NAC. As shown in Figure 6B, 5 mM NAC can 
mostly block h-FF induced ROS in cultured cells that are 
supportive of ROS production by h-FF. Consistent with 
h-FF, we observed that Bovine FF (b-FF) had a similar 
nature in FTSE cell ROS (Suppl Figure 6A).
The quantitative measurement of ROS production 
induced by h-FF, b-FF and controls were scored and 
summarized in Figure 6C (flow intensity) and Suppl 
Figure 6B (manually counted).
We also examined whether h-FF or b-FF has 
any effect on miR-182 and p53 expression in cultured 
FTE cells. Results shown that h-FF or b-FF in ex vivo 
culture FTE cells increased miR-182 and p53 expression 
(Suppl Figure 6C). Thus, h-FF can not only induce 
ROS production, but also increase the miR-182 and p53 
expression in cultured FTE cells.
DISCUSSION
The compelling evidence suggests that most HGSC 
arise from FTSE cells at the fimbriae [9]. In addition to 
the minority of patients with occasional genetic alterations 
[26], the causes of the disease remain largely unknown. 
Unbalanced high levels of ROS production can induce the 
expression of ROSmiRs (Figure 1). Since most ROSmiRs 
are either directly or indirectly regulated by P53, p53 
independent ROSmiRs should be critical in FTE cells 
when p53 is mutant. ROS or DNA stresses can robotically 
upregulate miR-182 [16, 27]. Unlike other ROSmiRs, 
ROS-induced miR-182 does not require p53 in some cell 
types [8, 28] as well as in normal FTSE cells observed 
in this study (Figure 1). In FTSE cells with normal p53, 
miR-182 overexpression triggers SIPS by upregulation 
of p21 (Figure 3). P21 (CDKN1A), encoding a potent 
cyclin-dependent kinase inhibitor, is a regulator of cell 
cycle progression at G1 through inhibiting the activity 
of cyclin-CDK2 or -CDK4 complexes. P21 is tightly 
controlled by p53, through which this protein mediates 
the p53-dependent cell cycle G1 phase arrest in response 
to a variety of stress stimuli, including ROS [29]. We have 
observed that administering ROS or simply overexpressing 
miR-182 induces p21 upregulation and triggers SIPS in 
FTSE cells (Figure 2). Our findings suggest that miR-182 
plays a central role in coordinating with p53 to regulate 
p21 for cellular senescence and to maintain DNA integrity 
in ROS-exposed cells.
In FTSE cells with p53 mutations, miR-182 
overexpression no longer enhances p21, but may function 
as an “Onco-miR” through the repression of several 
tumor suppressor genes, including BRCA1 [30] and 
FOXO3a [31], FOXO1 [32, 33], MITF1 [34], MTSS1 
[23], and RECK [35]. MiR-182 is overexpressed in most 
HGSC [23, 36] and its overexpression is associated with 
aggressive tumor growth and the worst clinical outcome 
[23]. Therefore, ROS or DNA stress-induced miR-182 
and other ROSmiR overexpression requires p53 for 
cell protection. We suggest that p53 dysfunction is a 
prerequisite for miR-182-mediated tumorigenesis through 
negative regulation of DNA repair and cell cycle pathway 
[22, 23]. Our study for the first time, illustrates the dual 
effects of miR-182 in FTSE cells and how these are closely 
related to the intactness of p53 function.
To evaluate how the FTSE cells react to stress when 
p53 is partly or completely lost or mutated, we established 
stable overexpression of miR-182 in the immortalized 
FTSE cell lines. DOX, a potent DNA damage reagent, 
induces significant SIPS in all cell types. However, in 
addition to higher senescent rate in cells with miR-182 
overexpression, these cells also obtained a significantly 
high-rate of senescence bypass when treated with ROS 
or DOX (Figure 4). Although we would like to test the 
cell lines with wild type P53, this kind of cell line is 
currently not available. To further evaluate the cellular 
nature of the senescence bypassed FTSE cells with and 
without miR-182 overexpression, FTE194 cells were 
stably overexpressed with luciferase and grafted into 
the intrabursa [22]. Although no tumor formation was 
noted in all of the mice by histologic evaluation, IVIS 
data showing long-lasting cell growth of FTSE with miR-
182 overexpression suggests the role of promoting cell 
proliferation and independent growth by miR-182 when 
p53 is partial inactivated (Figure 4). Current genetically 
engineered mouse models of ovarian cancer apply 
different combinations of MISRII-Cre, BRCA1/2, p53, 
Kras, PTEN, Dicer, Pax-8, et al [5, 37, 38]. One of the 
major functions for miR-182 involves the DNA damage 
response [23]. The chronically stressed cells with miR-
182 overexpression can occasionally transformed in vitro, 
detected by soft agar. DNA alterations were characterized 
by a significant increase of aneuploidy in FTSE cells with 
miR-182 overexpression (Figure 4).
Current study also shows that FTSE and FTCE cells 
react differently to ROS-induced β-catenin and miR-182 
expression (Figure 5). This difference may in part explain 
the different repairing rate of DNA damage between the 
FTSE and FTCE cells identified in this study and the 
previous report [18]. This difference provides a strong 
clue for the potential functional role of miR-182 in the 
early tumorigenesis of HGSC when p53 is mutant. We 
demonstrated that in the presence of normal P53, stress-
induced miR-182 overexpression mediated by β-catenin 
upregulates P21 and this will likely drive cells into 
SIPS. However, in cells with impaired or null p53, ROS 
induced miR-182 can increase the chance of senescence 
bypass (no-longer upregulating P21) and promote cell 
transformation or colony formation. Taken together, 
our current study suggests that the response to elevated 
Oncotarget38993www.impactjournals.com/oncotarget
ROS or DNA stress in FTSE cells may trigger a series of 
events, beginning with stress-induced miR-182 expression 
and p53 mutations, leading to impairments of the DNA 
damage response, DNA instability, bypassing senescence, 
thus increasing the risk of HGSC transformation 
(Figure 7) [4, 23].
The fimbriae are constantly exposed to 
environmental stresses (ovulation and pelvic 
inflammation). It is well recognized that ovulation is a 
major stressor for surrounding cells, causing trauma-
induced inflammation and local oxidative stress [12]. The 
effects of oxidative stress on female reproduction and 
related diseases involve many different pathophysiologic 
mechanisms [13], however, the mechanisms behind ROS-
mediated ovarian cancer development have not yet been 
investigated. h-FF is a complex body fluid and contains 
factors including steroid hormones, growth factors, pro-
inflammatory cytokines and interleukins, prostanoids 
and proteolytic enzymes [7, 39]. Therefore, ovulation is 
considered to be comparable to an inflammatory reaction 
and to be the major risk factor for ovarian cancer [40]. 
Prolonged and repeated exposure to an inflammatory 
environment can lead to increased DNA adduct formation 
and gene mutations and risk for malignant transformation 
[41, 42].
However, ovarian cancer often manifests itself 
after risk factors such as ovulation have come to an end 
and supposedly protective hormones i.e. progesterone 
against estrogen have gone to rise is a puzzle at the crux 
of the ovarian cancer problem [25]. We propose that 
follicular fluid exposure leads to DNA double stranded 
breaks and induces high expression of TP53. Constant 
DNA stress triggers TP53 mutations which is frequently 
seen in FTSE cells, defined as p53 signature [43, 44]. 
p53 signature does not present cellular malignancy 
features, but can be an early precursor lesion and may 
even take years (10–15 years as seen in most epithelial 
precursor lesion to malignant transformation) to harbor 
additional molecular changes and to develop occult 
STIC and invasive carcinoma. Therefore, understanding 
the link between the temporary induction of TP53 and 
the related molecular chain reaction in response to h-FF 
exposure and the acquisition of mutations in p53 in early 
precursor lesions will be the key for understanding the 
early tumorigenesis of HGSC [25]. In this study, we 
found h-FF can significantly induce a high level of ROS 
production and increase miR-182 and p53 expression in 
FTSE cells (Figure 6). Further study of the role of h-FF 
and its components in early precursor lesion of ovarian 
cancer are warranted. Future studies will be focused on 
developing the screening tests for miR-182 and mutant p53 
expression in FTE cells for risk and non-risk populations 
and establishing a mouse model with overexpression of 
miR-182 and mutant p53 in FTE cells for ovarian cancer 
development.
MATERIALS AND METHODS
Human fallopian tube tissues and cell lines
Human fallopian tube tissues were collected from 
premenopausal women for non-malignant gynecologic 
diseases at Northwestern University Prentice Women’s 
Hospital such as cysts and fibroids (34–48 years old) at 
Northwestern University Prentice Women’s Hospital. All 
of the samples were obtained from patients who were not 
taking hormonal or chemotherapy for at least 6 months 
prior to tissue collection and confirmed to be free of 
malignancy by histopathological examination (Suppl 
Table 4). The use of patient tissues was approved by the 
Figure 7: Proposed pathway for ROSmiR. Sketch diagram illustrated the proposed pathways for ROS-induced miRNA (ROSmiRs) 
expression and cellular responses in fallopian tube secretory epithelial cells. DDR: DNA damage repair.
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Institutional Review Board for Human Research (IRB) at 
Northwestern University and all patients provided written 
consent for the use of their tissue for research purposes. 
Ex vivo culture was established based on the published 
protocol [18] with modification. In brief, the fresh fimbriae 
tissues were incubated in a dissociation medium (DMEM, 
Life Technologies, Grand Island, NY) supplemented with 
1.4 mg/ml Pronase (Roche Applied Science, Indianapolis, 
IN) and 0.1 mg/ml DNase (Sigma-Aldrich, St. Louis, 
MO) for 48 h at 4°C with constant mild agitation. 
The dissociated epithelial cells were harvested by 
centrifugation and re-suspended in DMEM/Ham’s F12 1:1 
(Life Technologies, Grand Island, NY) supplemented with 
2% serum substitute, Ultroser G (PALL Life Sciences, 
Cergy-Saint-Christophe, France) and 1% penicillin/
streptomycin (Life Technologies, Grand Island, NY). 
The FTE cells were transferred onto Primaria™ culture 
dishes (Corning Inc, Corning, NY) and incubated for a 
minimum of one hour to three hours to remove fibroblasts 
and red blood cells. Cells were then cultured on 60 mm 
dishes covered with collagen IV from human placenta 
(Sigma-Aldrich, St. Louis, MO) and incubated at 37°C in 
a humidified 5% CO
2
 incubator.
Immortalized human FTSE cell lines and 
ovarian cancer cell lines
The FTE194 and FTE190 cells were immortalized 
by stable expressing human telomerase reverse 
transcriptase (hTERT) and SV40 large T antigen, which 
blocked the p53 and pRb tumor suppressor pathways in 
primary FTSEs. The FTE237 and FTE246 cells were 
immortalized by stable expression of hTERT, p53 shRNA, 
and CDK4R24C in primary FTSEs [45] (Suppl Table 2). 
These cells were cultured in DMEM/Ham’s F12 1:1 
supplemented with 2% serum substitute and 1% penicillin/
streptomycin.
Quantitative real-time RT-PCR
Total RNA was isolated using the mirVana™ 
RNA Isolation Kit (Ambion, Austin, TX). The detailed 
method was described previously [22]. Then cDNA was 
prepared by a Mir-X™ miRNA First Strand Synthesis 
Kit (Clontech, Mountain View, CA). The entire sequence 
of mature miRNA was used as miRNA-specific, 5′ 
primer (Suppl Table 5A). The 3′ primer for qPCR is 
the mRQ 3′ Primer supplied with the kit. For real-time 
PCR, cDNA was synthesized by SYBR Green real-time 
PCRmaster mix (Life Technologies, Grand Island, NY) 
using The Applied Biosystems® StepOnePlus™ Real-
Time PCR Systems (Applied Biosystems, Grand Island, 
NY) with sequence specific primers (Suppl Table 5B). 
Relative levels (∆Ct) were calculated by subtracting 
the cycle threshold (Ct) for internal control from the 
Ct. The mRNA and miRNA levels were normalized to 
GAPDH and U6, respectively. Results were obtained 
from at least three independent experiments performed 
in triplicate.
Western blotting, immunofluorescence, and 
quantitative H2AX detection
Western blotting
Cultured cells were harvested and lysed on ice in 
a NP40 cell lysis buffer (Invitrogen, Grand Island, NY) 
supplemented with protease inhibitor cocktail (Thermo 
Scientific, Waltham, MA). Total protein (30 μg) was 
separated by SDS-PAGE and electro-transferred onto 
polyvinylidene fluoride membrane (Invitrogen, Grand 
Island, NY). The membrane was incubated with primary 
antibodies overnight at 4°C. The specific horseradish 
peroxidase-conjugated goat anti-rabbit or goat anti-mouse 
secondary antibody (Bio-Rad, Hercules, CA) was used to 
blot the target proteins (Suppl Table 6), and the secondary 
antibody was detected by an enhanced chemiluminescence 
ECL detection kit (Bio-Rad, Hercules, CA).
Immunofluorescence staining
Cells grown on coverslips (22 × 22 mm) were 
washed in PBS and fixed with 4% paraformaldehyde 
for 10 minutes. Cells were then permeabilized in 0.2% 
Triton X-100 for 10 minutes, blocked in 5% normal goat 
serum for 30 minutes, and then incubated with specific 
primary antibodies including mouse antihuman phospho-
H2AX (1:200; EMD Millipore, Merck KGaA, Darmstadt, 
Germany) or mouse anti-human β-catenin (1:500, Santa 
Cruz Biotechnology, Dallas, TX) at 37°C for one hour. 
Mouse IgG was used as the negative control. After washing 
in PBS, cells were incubated with tetramethylrhodamine 
isothiocyanate-conjugated goat anti-mouse secondary 
antibody at room temperature for one hour. The nuclei 
were counterstained with 4,6-diamidino-2-phenylindole 
(DAPI). Three randomly selected fields of fluorescent 
images were captured under a fluorescence microscope 
(Delta Vision, Issaquah, WA), and a total of 100 cells 
were counted in each sample to calculate the percentage 
of positive-staining cells.
Quantitative H2AX detection
γ-H2AX was detected by ELISA using the HT 
γ-H2AX ELISA kit (Trevigen, Gaithersburg, MD) 
according to manufacturer’s instructions. In brief, 2 × 106 
FTE cells were cultured in 60 mm petridish until 70–80% 
confluent. Total protein was extracted from cell pellets 
and added to 96 well plate coated with γ-H2AX antibody. 
Goat anti-Mouse IgM HRP Conjugate was used and 
results were taken by chemiluminescent readings using 
a Cytation 3 Cell Imaging Multi-Mode Reader (BioTek, 
Winooski, VT).
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miRNA profile
Total RNA was isolated by miRVana extraction 
kit (Ambion, Austin, TX). RT-PCR was performed by 
Megaplex without pre-amplification of miRNA method 
(Applied Biosystems, Grand Island, NY). The microarray 
assay was performed on a 384 miRNA probe (Megaplex 
RT-PCR product, Applied Biosystems, Grand Island, 
NY) and following the protocol of the manufacturer. The 
real-time data were analyzed by using SDS RQ manager 
software (Applied Biosystems, Grand Island, NY). 
Individual miRNA expression was analyzed by using 
individual miRNA primers specific for real-time PCR 
reactions.
mRNA profile
Total RNA was isolated by mirVana™ method. 
Biotin labeled cRNA was generated from high quality 
total RNA. Purified second strand cDNA along with 
biotin UTPs were used to generate biotinylated, antisense 
RNA of each mRNA in an in vitro transcription (IVT) 
reaction. The labeled cRNAs were hybridized at 55°C 
overnight with the HumanHT-12 v4 Expression Beadchip 
(Illumina, San Diego, CA) and washed the following day. 
Signals was developed with Streptavidin-Cy3 and scanned 
with an Illumina iScan System. Quantile normalization 
and subsequent data processing were performed using 
the GeneSpring GX v13.0 software package (Agilent 
Technologies, Santa Clara, CA). DAVID Bioinformatics 
Resources 6.7 was used for pathway analysis. The 
microarray data have been deposited in NCBI GEO 
database under the accession number GSE (pending).
Stable and transient miRNA and si-RNA gene 
expression
Anti-miR-182 and scramble control were from 
Regulus Therapeutics. The si-β-catenin and si-P21 
were purchased from Life Technologies. The transient 
transfections for miRNA mimic and anti-miR-182 
were previously described [22]. Pre-miR-182 lentivirus 
was prepared as previously described and its stable 
overexpression was made in FTE190, FTE194, FTE237, 
and FTE246 cell lines by the method described previously 
[23]. sh-p53 pLKO.1 was obtained from Addgene 
(Cambridge, MA). Ad-S37A-β-cat-HA was provided by 
Jan Kitajewski at Columbia University, New York.
Senescence stain and quantitative detection
Senescence-associated β-Gal stain
Senescence-associated β-Gal stain were used as 
previously described [16]. In brief, cells were seeded onto 
coverslips, placed in 6-well plates overnight, and then 
treated with the test compounds: H
2
O
2
 (100 or 200 μM), 
or DOX (0.2 μg/mL) for 48 hrs. Cells were fixed with 2% 
formaldehyde and 0.2% glutaraldehyde in PBS at room 
temperature for 5 minutes. After washing in PBS, cells 
were stained with staining solution containing 1 mg/mL 
X-gal (Life Technologies, Grand Island, NY) and incubated 
in a CO
2
-free incubator at 37°C for 16 hours. Blue cells 
were counted under the microscope and statistically 
analyzed. Three randomly selected fields (1 × 1 mm2) of 
images were captured to count the senescence rate (%).
Quantitative detection for senescence
Cellular senescence was measured by fluorimetric 
beta-galactosidase activity using Cellular Senescence 
Assay Kit (Cell Biolabs Inc. San Diego, CA). In brief, 
cells were seeded on 6-well plates overnight and then 
treated with the test compounds: H
2
O
2
 (100 μM), or DOX 
(0.2 μg/mL) for 48 hrs. At the end of treatment, the cell 
lysates were prepared for the determination of SA-β-
galactosidase activity using the fluorescence plate reader 
at 360/465 nm. Cell lysate protein concentration was 
determined for normalization cell number and expressed 
as RLU/cell number.
Chronic ROS stress
The chronic ROS stress on the immortalized FTSE 
cells was performed by reapplication of a low dose of 
H
2
O
2
. In brief, FTSE cells including FTE190, FTE194, 
FTE237 and FT246, with and without stable miR-182 
overexpression were cultured in 100 mm dishes and pulse 
treated with 10 μM H
2
O
2
 for three times per week. This 
low dose treatment lasted for 15 passages then the H
2
O
2
 
concentration was increased to 100 μM for an additional 
2–3 passages.
Soft agar colony-formation assay
Soft agar colony formation assay was performed 
as previously described [22]. The cells (0.75 × 104 cells) 
were suspended in 3 mL of culture medium containing 
0.3% agar (USB Corporation, OH, USA) and seeded onto 
a base layer of 3 mL of a 0.6% agar bed in 60-mm tissue 
culture dishes. After up to 6 weeks, colonies were stained 
with 0.005% crystal violet and photographed. Colonies 
> 0.1 mm in diameter were counted, and the average 
numbers (n = 3) in each group were calculated.
Xenograft in nude mice
Senescence bypass cells for FTSE cells with and 
without miR-182 overexpression were engrafted in 
intraovarian bursa of female nude mice (NCI-Frederick) 
as previously described [22]. The xenograft growth was 
monitored by IVIS weakly. Experiments were approved 
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by the Institutional Animal Care and Use Committee of 
Northwestern University.
Cytogenetic analysis
Cells were grown in 60 mm dishes and KaryoMAX® 
Colcemid (10 μl/mL, Life Technologies, Grand Island, 
NY) was added when cells reached 85% confluence, 
incubating for 2 hours and rinsed with PBS. Then 
cells were suspended by 2 mL 0.25% trypsin (Life 
Technologies, Grand Island, NY) and centrifuged. The 
pre-warmed hypotonic solution (0.075 M potassium 
chloride and 0.9% sodium citrate, 1:1) was added and 
cells were incubated at 37°C, for 16 min. Cells were 
fixed in fixation buffer (methanol: glacial acetic acid, 
3:1) overnight and dropped on ice-cold slide. Slides were 
stained by Giemsa and photographed in oil lenses for 
karyotype analysis.
FACS sorting for fallopian tube secretory 
(FTSE) and ciliated (FTCE) cells
Primary FTE cells were isolated and cultured up 
to two weeks. Single cell suspensions were prepared in 
HBSS buffer and labeled with mouse anti-human LhS28-
APC antibody (Novus, Littleton, CO), which recognizes 
the basal bodies of cilia in ciliated epithelial cells [47], 
and Pacific Blue mouse anti-human CD326 (EpCAM) 
(epithelial marker) antibody (BioLegend, San Diego, 
CA), a marker for epithelial cells [48]. The cells were 
sorted using BD FACSAria 5-Laser Flow Cytometry 
(BD Biosciences, Franklin Lakes, NJ) with 488 nm and 
633 nm lasers for excitation. Statistics and images were 
then created offline using FCS EXPRESS VERSION 3 
(De Novo Software, Glendale, CA). The sorted cells were 
collected in DMEM/F12 medium with 2% Ultroser G and 
cultured for the related assays.
Human and bovine follicular fluid
The use of human follicular fluid (h-FF) was 
approved by IRB at Northwestern University. Four h-FF 
samples were obtained from donors undergoing oocyte 
retrieval as part of their in vitro fertilization procedure 
at Northwestern Hospital IVF laboratory with a written 
informed patient consent. Bovine follicular fluid (b-FF) 
was acquired from the Aurora Packing Company (Aurora, 
IL, USA). Follicular fluid was centrifuged at 500 g for 
10 min at 4°C, and the supernatant was aliquotted and 
stored at −80°C until use. Both of h-FF and b-FF were 
heated to 56°C for 30 min prior to use.
ROS detection and measurement
Intracellular ROS levels in human fallopian tube 
epithelial (FTE) cells were measured using the dye, 
dihydroethidium (DHE) (Molecular Probe Inc., Eugene, 
OR) by immunofluorescence microscope imaging and 
flow cytometry [49].
For ROS detection using fluorescence microscope 
imaging, primary ex vivo culture FTE cells (1 × 105 cells) 
were treated with h-FF or H
2
O
2
 for 4–24 hours, FTE cells 
were loaded with DHE (10 μM) and incubated at 37°C in 
the dark for 30 min. The fluorescent images were captured 
immediately with a Nikon C2+ Confocal Microscope 
System (Nikon, Melville, NY) at excitation and emission 
wavelengths of 520 and 610 nm, respectively.
For ROS detection using flow cytometry, FTE 
cells (5 × 105) were cultured on 60-mm Petri dishes. 
After treatment with h-FF or b-FF and/or 5 mM NAC 
for 2 or 24 hours, FTE cells were loaded with DHE (10 
μM) for 30 min at 37°C in the dark. Pulse treatment 
with 100 μM of H
2
O
2
 (3 times with 1 hour interval) 
served as positive control. The dosage of H
2
O
2
 being 
used is according to clonogenic cell killing experiment 
and references (Data not shown). A total of 1 × 104 cells 
were analyzed within 60 min of staining by a FASC 
caliber flow cytometer (BD LSRFortessa Analyzer, 
BD Biosciences, Franklin Lakes, NJ). The relative 
increase in ROS was calculated by comparing the mean 
fluorescence intensity of DHE stained-treatment groups 
to that of the untreated group.
Statistical analysis
All data are presented as means and standard errors 
of at least three independent experiments. The Student 
t test was used for comparisons between two groups of 
experiments, and one-way ANOVA analysis was used for 
comparisons among three or more groups. Statistical tests 
were two-sided and P < 0.05 was considered statistically 
significant.
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